Oncolytics Biotech Inc. - Common Shares (ONCY)

Oncolytics Biotech Inc is a biotechnology company focused on developing innovative cancer therapies using a proprietary virus-based approach

The company’s leading product candidate is a proprietary oncolytic virus designed to selectively target and destroy cancer cells while sparing normal healthy tissue. By harnessing the power of the immune system in combination with the virus, Oncolytics aims to create more effective treatment options for various types of cancer, ultimately enhancing patient outcomes. The company is actively involved in clinical trials to evaluate the safety and efficacy of its treatments, contributing to the advancement of cancer care.